GeneDx Holdings Corp. (WGS)
NASDAQ · Healthcare
GeneDx Holdings Corp. Operating Income 2019–2025
GeneDx Holdings Corp. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- GeneDx Holdings Corp. operating income for the quarter ending March 31, 2026 was -57.5 M, a 1162.82% increase year-over-year.
- GeneDx Holdings Corp. operating income for the twelve months ending March 31, 2026 was -56.3 M, a 24.90% decrease year-over-year.
- GeneDx Holdings Corp. annual operating income for 2025 was -13.1 M, a 43.67% decrease from 2024.
- GeneDx Holdings Corp. annual operating income for 2024 was -23.2 M, a 87.15% decrease from 2023.
- GeneDx Holdings Corp. annual operating income for 2023 was -180.6 M, a 72.95% decrease from 2022.
- GeneDx Holdings Corp. annual operating income for 2022 was -667.7 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GeneDx Holdings Corp. Operating Income — FAQ
GeneDx Holdings Corp. (WGS) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is GeneDx Holdings Corp.'s operating income?
GeneDx Holdings Corp. (WGS) reported operating income of -$13M for fiscal 2025.
Where can I see WGS's operating income history?
The chart and table above show GeneDx Holdings Corp.'s operating income by year and by quarter, including the growth rate.